Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients
Journal of Clinical and Experimental Hematopathology · 2025
DOI: 10.3960/jslrt.24078 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2025. Verfasst von Kiyoshi Okazuka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Pharmaceutical Company Limited, Tokyo, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Brentuximab Vedotin, Hodgkin Disease. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Takeda Pharmaceutical Company Limited, Tokyo, Japan.
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
- Division of Hematology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
- ICON Clinical Research GK, Osaka, Japan.
- Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Zitieren
APA
Okazuka, K., Shimizu, T., Tawara, R., Matsuo, M., Ichihara, K., & Izutsu, K. (2025). Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.24078
Vancouver
Okazuka K, Shimizu T, Tawara R, Matsuo M, Ichihara K, Izutsu K. Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients. Journal of Clinical and Experimental Hematopathology. 2025. doi:10.3960/jslrt.24078
BibTeX
@article{Okazuka2025,
author = {Okazuka, Kiyoshi and Shimizu, Takayuki and Tawara, Ryosuke and Matsuo, Masako and Ichihara, Kayoko and Izutsu, Koji},
title = {Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2025},
doi = {10.3960/jslrt.24078}
}
EUVIMED